Editorial pass: sharper headline; filed as context: no real AI gain or problem (gain unsupported, problem absent).
The exact text we saved
This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.
TRUVACE RECORD VERSION record: TRV-2026-1189 version: 3 kind: revised reason: Editorial pass: sharper headline; filed as context: no real AI gain or problem (gain unsupported, problem absent). timestamp: 2026-11-04T09:55:41.217465Z status: published lens: general sector: health headline: Rapid serum-based differentiation of ovarian tumors and assessment of post-treatment disease-free status using portable Raman spectroscopy and machine learning dek: Rapid, low-cost tools for ovarian tumor discrimination and post-treatment assessment remain limited because conventional serum biomarkers such as CA125 have suboptimal sensitivity and specificity. Serum contains proteins, lipids, carbohydrates, and nucleic acids that generate disease-related spectrochemical fingerprints, which portable Raman spectroscopy can capture with minimal sample preparation. We investigated serum Raman profiling for ovarian tumor discrimination and cross-sectional characterization of post… gain_title: Portable Raman spectroscopy with machine learning offers a rapid, low-cost serum approach to distinguish ovarian tumors and assess post-treatment status, where CA125 is limited. problem_title: (none) trace_subject: (none) gain_reading: Portable Raman spectroscopy with machine learning offers a rapid, low-cost serum approach to distinguish ovarian tumors and assess post-treatment status, where CA125 is limited. gain_evidence: (none) problem_reading: (none) problem_evidence: (none) quick_read: Rapid, low-cost tools for ovarian tumor discrimination and post-treatment assessment remain limited because conventional serum biomarkers such as CA125 have suboptimal sensitivity and specificity. Serum contains proteins, lipids, carbohydrates, and nucleic acids that generate disease-related spectrochemical fingerprints, which portable Raman spectroscopy can capture with minimal sample preparation. We investigated serum Raman profiling for ovarian tumor discrimination and cross-sectional characterization of post-treatment disease-free status. Serum samples from 280 participants (85 benign, 82 malignant, and 113 independent follow-up patients) were analyzed over 400-1800 cm⁻ 1 . limitation: tag: Context key_points: Rapid, low-cost tools for ovarian tumor discrimination and post-treatment assessment remain limited because conventional serum biomarkers such as CA125 have suboptimal sensitivity and specificity. | Serum contains proteins, lipids, carbohydrates, and nucleic acids that generate disease-related spectrochemical fingerprints, which portable Raman spectroscopy can capture with minimal sample preparation. | We investigated serum Raman profiling for ovarian tumor discrimination and cross-sectional characterization of post-treatment disease-free status. rundown: Rapid, low-cost tools for ovarian tumor discrimination and post-treatment assessment remain limited because conventional serum biomarkers such as CA125 have suboptimal sensitivity and specificity. Serum contains proteins, lipids, carbohydrates, and nucleic acids that generate disease-related spectrochemical fingerprints, which portable Raman spectroscopy can capture with minimal sample preparation. We investigated serum Raman profiling for ovarian tumor discrimination and cross-sectional characterization of post-treatment disease-free status. Serum samples from 280 participants (85 benign, 82 malignant, and 113 independent follow-up patients) were analyzed over 400-1800 cm⁻ 1 . sources: - peer_reviewed | Analytical and Bioanalytical Chemistry | https://doi.org/10.1007/s00216-026-06823-5 | 2026-09-23 prev: ee6441ed1c83be7163822648f9f9d83a681b8a6599abea834815d1553c27cdad
- SHA-256 hash
- da270dc95edbae889e37b1a5eb5c19fc274434751beb8198d640466e20f6ed92
- Previous version’s hash
- ee6441ed1c83be7163822648f9f9d83a681b8a6599abea834815d1553c27cdad
How to check it yourself, without trusting this page
Download any version from /api/record/TRV-2026-1189 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.
ace